Vunakizumab is a recombinant human IgG?? monoclonal antibody specifically designed to target and neutralize interleukin-17A (IL-17A). By binding to IL-17A, Vunakizumab effectively prevents its interaction with the IL-17 receptor, thereby inhibiting the pro-inflammatory pathways associated with this cytokine. This antibody is particularly useful in research focused on autoimmune disorders, including psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis, where IL-17A plays a key role in disease pathogenesis.
Vunakizumab is a recombinant human IgG?? monoclonal antibody specifically designed to target and neutralize interleukin-17A (IL-17A). By binding to IL-17A, Vunakizumab effectively prevents its interaction with the IL-17 receptor, thereby inhibiting the pro-inflammatory pathways associated with this cytokine. This antibody is particularly useful in research focused on autoimmune disorders, including psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis, where IL-17A plays a key role in disease pathogenesis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
